For reprint and licensing requests for this article, click here.
More From Employee Benefit News
Employers face a new GLP-1 question: Are the drugs worth it?
As GLP-1 spending climbs, employers are asking whether the drugs deliver enough value. Better data could help them measure the payoff more accurately.
As AI changes pay, benefits leaders need a new playbook
With salary budgets holding steady and AI reshaping rewards, employers are looking to transparency, career growth and other benefits to retain top talent.
Bill targets $10M+ retirement accounts with new distribution rules
Some ultrahigh net worth clients would be affected by a change to retirement plan contribution and distribution rules that's under consideration in Congress.
Benefits Think Inside Medicare’s new GLP-1 demonstration
A look at what the Medicare GLP-1 Bridge Program covers, what it doesn't, and what plan sponsors need to know.
Why some advisors prefer HSAs over IRAs for retirement savings
At face-value, HSAs are for short-term medical expenses, but advisors suggest paying out of pocket to maximize HSA funds for investing and tax-free growth.